On this page
Rod Canion
Insider
First SEC filing: July 30, 2007 · Latest: Feb. 14, 2008
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 28, 2020 | IVZ | A | 2,719 | · | · | 122,931 Direct | +2.26% | Acquired | (price as of 2026-10-05) |
| July 29, 2020 | IVZ | A | 3,419 | · | · | 120,212 Direct | +2.93% | Acquired | (price as of 2026-10-05) |
| April 24, 2020 | IVZ | A | 4,647 | · | · | 116,793 Direct | +4.14% | Acquired | (price as of 2026-10-05) |
| Jan. 30, 2020 | IVZ | A | 2,056 | · | · | 112,146 Direct | +1.87% | Acquired | (price as of 2026-10-05) |
| Oct. 25, 2019 | IVZ | A | 2,126 | · | · | 110,090 Direct | +1.97% | Acquired | (price as of 2026-10-05) |
| July 26, 2019 | IVZ | A | 1,848 | · | · | 107,964 Direct | +1.74% | Acquired | (price as of 2026-10-05) |
| May 13, 2019 | IVZ | P | 10,000 | $19.84 | $198,400 | 106,116 Direct | +10.40% | Acquired | 53.7% (price as of 2026-10-05) |
| May 2, 2019 | IVZ | P | 10,000 | $21.24 | $212,400 | 96,116 Direct | +11.61% | Acquired | 43.6% (price as of 2026-10-05) |
| April 26, 2019 | IVZ | A | 1,665 | · | · | 86,116 Direct | +1.97% | Acquired | (price as of 2026-10-05) |
| Feb. 21, 2019 | IVZ | P | 20,000 | $18.89 | $377,800 | 84,451 Direct | +31.03% | Acquired | 61.5% (price as of 2026-10-05) |
| Feb. 8, 2019 | IVZ | P | 10,000 | $17.97 | $179,700 | 64,451 Direct | +18.37% | Acquired | 69.7% (price as of 2026-10-05) |
| Jan. 31, 2019 | IVZ | A | 1,989 | · | · | 54,451 Direct | +3.79% | Acquired | (price as of 2026-10-05) |
| Oct. 19, 2018 | IVZ | A | 1,649 | · | · | 52,462 Direct | +3.25% | Acquired | (price as of 2026-10-05) |
| July 27, 2018 | IVZ | A | 1,395 | · | · | 50,813 Direct | +2.82% | Acquired | (price as of 2026-10-05) |
| April 27, 2018 | IVZ | A | 1,225 | · | · | 49,418 Direct | +2.54% | Acquired | (price as of 2026-10-05) |
| Feb. 1, 2018 | IVZ | A | 1,006 | · | · | 48,193 Direct | +2.13% | Acquired | (price as of 2026-10-05) |
| Oct. 26, 2017 | IVZ | A | 982 | · | · | 47,187 Direct | +2.13% | Acquired | (price as of 2026-10-05) |
| July 28, 2017 | IVZ | A | 1,055 | · | · | 46,205 Direct | +2.34% | Acquired | (price as of 2026-10-05) |
| April 28, 2017 | IVZ | A | 1,100 | · | · | 45,150 Direct | +2.50% | Acquired | (price as of 2026-10-05) |
| Jan. 27, 2017 | IVZ | A | 1,228 | · | · | 44,050 Direct | +2.87% | Acquired | (price as of 2026-10-05) |
| Oct. 28, 2016 | IVZ | A | 1,270 | · | · | 42,822 Direct | +3.06% | Acquired | (price as of 2026-10-05) |
| July 29, 2016 | IVZ | A | 1,242 | · | · | 41,552 Direct | +3.08% | Acquired | (price as of 2026-10-05) |
| April 29, 2016 | IVZ | A | 1,168 | · | · | 40,310 Direct | +2.98% | Acquired | (price as of 2026-10-05) |
| Jan. 29, 2016 | IVZ | A | 1,211 | · | · | 39,142 Direct | +3.19% | Acquired | (price as of 2026-10-05) |
| Oct. 30, 2015 | IVZ | A | 1,092 | · | · | 37,931 Direct | +2.96% | Acquired | (price as of 2026-10-05) |
| July 31, 2015 | IVZ | A | 939 | · | · | 36,839 Direct | +2.62% | Acquired | (price as of 2026-10-05) |
| May 1, 2015 | IVZ | A | 871 | · | · | 35,900 Direct | +2.49% | Acquired | (price as of 2026-10-05) |
| Jan. 30, 2015 | IVZ | A | 986 | · | · | 35,029 Direct | +2.90% | Acquired | (price as of 2026-10-05) |
| Oct. 31, 2014 | IVZ | A | 895 | · | · | 34,043 Direct | +2.70% | Acquired | (price as of 2026-10-05) |
| Aug. 1, 2014 | IVZ | A | 958 | · | · | 33,148 Direct | +2.98% | Acquired | (price as of 2026-10-05) |
| May 2, 2014 | IVZ | A | 1,008 | · | · | 32,190 Direct | +3.23% | Acquired | (price as of 2026-10-05) |
| Jan. 31, 2014 | IVZ | A | 714 | · | · | 31,182 Direct | +2.34% | Acquired | (price as of 2026-10-05) |
| Nov. 1, 2013 | IVZ | A | 701 | · | · | 30,468 Direct | +2.35% | Acquired | (price as of 2026-10-05) |
| Aug. 1, 2013 | IVZ | A | 718 | · | · | 29,767 Direct | +2.47% | Acquired | (price as of 2026-10-05) |
| May 1, 2013 | IVZ | A | 755 | · | · | 29,049 Direct | +2.67% | Acquired | (price as of 2026-10-05) |
| Feb. 1, 2013 | IVZ | A | 855 | · | · | 28,294 Direct | +3.12% | Acquired | (price as of 2026-10-05) |
| Nov. 2, 2012 | IVZ | A | 973 | · | · | 27,439 Direct | +3.68% | Acquired | (price as of 2026-10-05) |
| July 27, 2012 | IVZ | A | 1,073 | · | · | 26,466 Direct | +4.23% | Acquired | (price as of 2026-10-05) |
| April 27, 2012 | IVZ | A | 946 | · | · | 25,393 Direct | +3.87% | Acquired | (price as of 2026-10-05) |
| Jan. 27, 2012 | IVZ | A | 1,033 | · | · | 24,447 Direct | +4.41% | Acquired | (price as of 2026-10-05) |
| Oct. 25, 2011 | IVZ | A | 1,263 | · | · | 23,414 Direct | +5.70% | Acquired | (price as of 2026-10-05) |
| July 27, 2011 | IVZ | A | 1,066 | · | · | 22,151 Direct | +5.06% | Acquired | (price as of 2026-10-05) |
| April 28, 2011 | IVZ | A | 951 | · | · | 21,085 Direct | +4.72% | Acquired | (price as of 2026-10-05) |
| Jan. 28, 2011 | IVZ | A | 963 | · | · | 20,134 Direct | +5.02% | Acquired | (price as of 2026-10-05) |
| Oct. 26, 2010 | IVZ | A | 1,062 | · | · | 19,171 Direct | +5.86% | Acquired | (price as of 2026-10-05) |
| July 28, 2010 | IVZ | A | 1,228 | · | · | 18,109 Direct | +7.27% | Acquired | (price as of 2026-10-05) |
| April 29, 2010 | IVZ | A | 1,003 | · | · | 16,881 Direct | +6.32% | Acquired | (price as of 2026-10-05) |
| Jan. 29, 2010 | IVZ | A | 906 | · | · | 15,878 Direct | +6.05% | Acquired | (price as of 2026-10-05) |
| Oct. 21, 2009 | IVZ | A | 767 | · | · | 14,972 Direct | +5.40% | Acquired | (price as of 2026-10-05) |
| July 28, 2009 | IVZ | A | 916 | · | · | 14,205 Direct | +6.89% | Acquired | (price as of 2026-10-05) |
| April 24, 2009 | IVZ | A | 1,192 | · | · | 13,289 Direct | +9.85% | Acquired | (price as of 2026-10-05) |
| Feb. 2, 2009 | IVZ | A | 1,401 | · | · | 12,097 Direct | +13.10% | Acquired | (price as of 2026-10-05) |
| Oct. 30, 2008 | IVZ | A | 1,217 | · | · | 10,696 Direct | +12.84% | Acquired | (price as of 2026-10-05) |
| July 25, 2008 | IVZ | A | 787 | · | · | 9,479 Direct | +9.05% | Acquired | (price as of 2026-10-05) |
| May 16, 2008 | IVZ | A | 714 | · | · | 8,692 Direct | +8.95% | Acquired | (price as of 2026-10-05) |
| Feb. 20, 2008 | IVZ | A | 1,593 | · | · | 7,978 Direct | +24.95% | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 30, 2007 | IVZ | Ordinary Share par value $0.10 per share | 24,621 | Direct |